Voyager Therapeutics Inc

NASDAQ:VYGR   2:19:52 PM EDT
10.95
-0.08 (-0.72%)
Products, Regulatory

Voyager Therapeutics Provides Regulatory Update On Vy-Htt01 Program

Published: 10/12/2020 20:11 GMT
Voyager Therapeutics Inc (VYGR) - Voyager Therapeutics Provides Regulatory Update on Vy-htt01 Program.
Voyager Therapeutics Inc - Received Feedback From U.S. FDA on Investigational New Drug Submission for Vy-htt01 for Treatment of Huntington's Disease.
Voyager Therapeutics -notified That Ind for Vy-htt01 Placed on Clinical Hold Pending Resolution of Certain Chemistry, Manufacturing & Controls Matters.
Voyager Therapeutics Inc - Plans to Work Closely With FDA to Resolve Matters and Promptly Begin Clinical Evaluation of Vy-htt01.